Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.

Molecular cancer - 1 Mar 2021

Huang Xing, Zhang Gang, Tang Tianyu, Liang Tingbo

Abstract excerpt

BACKGROUND: Although mRNA vaccines have been effective against multiple cancers, their efficacy against pancreatic adenocarcinoma (PAAD) remains undefined. Accumulating evidence suggests that immunotyping can indicate the comprehensive immune status in tumors and their immune microenvironment, which is closely associated with therapeutic response and vaccination potential. The aim of this study was to identify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Vaccines
Share to Immunophenotyping

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pancreatic Neoplasms

Share to Sequence Analysis, RNA

Share to Survival Analysis

Share to Tumor Microenvironment

Share to Vaccines, Synthetic

Source

Open in PubMed Open full text

Identifiers

PMID: 33648511
DOI: 10.1186/s12943-021-01310-0
PMCID: PMC7917175

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.PMID 33648511Read ↗

Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA VaccinationSemantic proximity Read ↗

Identifying tumor antigens and immuno‐subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccineSemantic proximity Read ↗

Immuno-phenotypes of Pancreatic Ductal Adenocarcinoma: Metaanalysis of transcriptional subtypesSemantic proximity Read ↗

Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypesSemantic proximity Read ↗

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.Semantic proximity Read ↗

Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma.Semantic proximity Read ↗

Immune Subtyping for Pancreatic Cancer with Implication in Clinical Outcomes and Improving ImmunotherapySemantic proximity Read ↗

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccineSemantic proximity Read ↗

Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune SubtypeSemantic proximity Read ↗

Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance.Semantic proximity Read ↗

Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypesSemantic proximity Read ↗

Comprehensive Genomic Analysis of the Prognostic and Immunological Characteristics of Tertiary Lymphoid structures and CD8+ T-cells in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.